EGFR and posterior cortical atrophy: In our study, USP13 was found to be possibly involved in EGFR signaling, indicating that USP13 inhibition may interrupt the signaling cascade; however, the effect of USP13 inhibition (genetically or pharmaceutically) on the malignancy phenotype of PCa cells and the expression of signaling components still need further validation.